Abstract
The use of extracellular vesicles (EVs) for immunomodulation has allowed the advancement of therapeutic options for several pathologies that involve immunological mechanisms, including graft versus host disease (GVHD). Therefore, studying the effectiveness of using EVs for the prevention and control of GVHD becomes essential for the establishment of future clinical protocols. Therefore, t…